Barbara Kermode-Scott. Show Affiliations »
Abstract
Entities: Gene
Mesh： See more » CanadaCyclooxygenase Inhibitors/adverse effectsDrug ApprovalGovernment AgenciesHumansLactones/adverse effectsSulfones/adverse effectsUnited StatesUnited States Food and Drug Administration
Substances： See more » Cyclooxygenase InhibitorsLactonesSulfonesrofecoxib
Year: 2005 PMID： 15649923 PMCID： PMC544456 DOI： 10.1136/bmj.330.7483.113-a
Source DB: PubMed Journal: BMJ ISSN： 0959-8138